From: Prognostic biomarker IL17A correlated with immune infiltrates in head and neck cancer
Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
Age | 501 | 1.252 (0.956–1.639) | 0.102 | 1.294 (0.971–1.725) | 0.079 |
Gender | 501 | 0.764 (0.574–1.018) | 0.066 | 0.831 (0.613–1.128) | 0.235 |
Clinical stage | 487 | 1.217 (0.878–1.688) | 0.238 | 0.748 (0.411–1.362) | 0.342 |
T stage | 486 | 1.245 (0.932–1.661) | 0.137 | 1.459 (0.879–2.424) | 0.144 |
M stage | 476 | 4.745 (1.748–12.883) | 0.002*** | 4.853 (1.730–13.610) | 0.003*** |
N stage | 479 | 1.384 (1.040–1.842) | 0.026* | 1.502 (1.090–2.068) | 0.013* |
IL17A | 501 | 0.250 (0.081–0.772) | 0.016* | 0.248 (0.075–0.818) | 0.022* |